These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31016665)

  • 1. Detection of Drug-Induced Cholestasis Potential in Sandwich-Cultured Human Hepatocytes.
    Deferm N; Richert L; Van Brantegem P; De Vocht T; Qi B; de Witte P; Bouillon T; Annaert P
    Methods Mol Biol; 2019; 1981():335-350. PubMed ID: 31016665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocyte-based in vitro model for assessment of drug-induced cholestasis.
    Chatterjee S; Richert L; Augustijns P; Annaert P
    Toxicol Appl Pharmacol; 2014 Jan; 274(1):124-36. PubMed ID: 24211272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The C-DILI™ Assay: An Integrated In Vitro Approach to Predict Cholestatic Hepatotoxicity.
    Jackson JP; Brouwer KR
    Methods Mol Biol; 2019; 1981():75-85. PubMed ID: 31016648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-induced cholestasis risk assessment in sandwich-cultured human hepatocytes.
    Oorts M; Baze A; Bachellier P; Heyd B; Zacharias T; Annaert P; Richert L
    Toxicol In Vitro; 2016 Aug; 34():179-186. PubMed ID: 27046439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inter-individual differences in the susceptibility of primary human hepatocytes towards drug-induced cholestasis are compound and time dependent.
    Parmentier C; Hendriks DFG; Heyd B; Bachellier P; Ingelman-Sundberg M; Richert L
    Toxicol Lett; 2018 Oct; 295():187-194. PubMed ID: 29913214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organotypic 3D HepaRG Liver Model for Assessment of Drug-Induced Cholestasis.
    Ramaiahgari SC; Ferguson SS
    Methods Mol Biol; 2019; 1981():313-323. PubMed ID: 31016663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro model systems to investigate bile salt export pump (BSEP) activity and drug interactions: A review.
    Cheng Y; Woolf TF; Gan J; He K
    Chem Biol Interact; 2016 Aug; 255():23-30. PubMed ID: 26683212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-induced cholestasis detection in cryopreserved rat hepatocytes in sandwich culture.
    Oorts M; Richert L; Annaert P
    J Pharmacol Toxicol Methods; 2015; 73():63-71. PubMed ID: 25828992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptomic Analysis of Cholestatic Compounds In Vitro.
    Parmentier C; Couttet P; Uteng M; Wolf A; Richert L
    Methods Mol Biol; 2019; 1981():175-186. PubMed ID: 31016655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nimesulide and 4'-Hydroxynimesulide as Bile Acid Transporters Inhibitors Are Contributory Factors for Drug-Induced Cholestasis.
    Zhou L; Pang X; Jiang J; Zhong D; Chen X
    Drug Metab Dispos; 2017 May; 45(5):441-448. PubMed ID: 28202577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of the Clinical Risk of Drug-Induced Cholestatic Liver Injury Using an In Vitro Sandwich Cultured Hepatocyte Assay.
    Susukida T; Sekine S; Nozaki M; Tokizono M; Ito K
    Drug Metab Dispos; 2015 Nov; 43(11):1760-8. PubMed ID: 26329788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vitro Assay System to Detect Drug-Induced Bile Acid-Dependent Cytotoxicity Using Hepatocytes.
    Takemura A; Ito K
    Methods Mol Biol; 2022; 2544():119-127. PubMed ID: 36125714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Species differences in hepatobiliary disposition of taurocholic acid in human and rat sandwich-cultured hepatocytes: implications for drug-induced liver injury.
    Yang K; Pfeifer ND; Köck K; Brouwer KL
    J Pharmacol Exp Ther; 2015 May; 353(2):415-23. PubMed ID: 25711339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of bile salt transport by drugs associated with liver injury in primary hepatocytes from human, monkey, dog, rat, and mouse.
    Zhang J; He K; Cai L; Chen YC; Yang Y; Shi Q; Woolf TF; Ge W; Guo L; Borlak J; Tong W
    Chem Biol Interact; 2016 Aug; 255():45-54. PubMed ID: 27000539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic 3D spheroid models for the detection and study of compounds with cholestatic liability.
    Hendriks DF; Fredriksson Puigvert L; Messner S; Mortiz W; Ingelman-Sundberg M
    Sci Rep; 2016 Oct; 6():35434. PubMed ID: 27759057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Model Systems for Studying the Role of Canalicular Efflux Transporters in Drug-Induced Cholestatic Liver Disease.
    Stieger B; Mahdi ZM
    J Pharm Sci; 2017 Sep; 106(9):2295-2301. PubMed ID: 28385542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organic solute transporter OSTα/β is overexpressed in nonalcoholic steatohepatitis and modulated by drugs associated with liver injury.
    Malinen MM; Ali I; Bezençon J; Beaudoin JJ; Brouwer KLR
    Am J Physiol Gastrointest Liver Physiol; 2018 May; 314(5):G597-G609. PubMed ID: 29420067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic Activation of Cholestatic Drug-Induced Bile Acid-Dependent Toxicity in Human Sandwich-Cultured Hepatocytes.
    Ogimura E; Tokizono M; Sekine S; Nakagawa T; Bando K; Ito K
    J Pharm Sci; 2017 Sep; 106(9):2509-2514. PubMed ID: 28465153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vesicle- and Hepatocyte-Based Assays for Identification of Drug Candidates Inhibiting BSEP Function.
    Van Brantegem P; Deferm N; Qi B; De Vocht T; Annaert P
    Methods Mol Biol; 2019; 1981():55-73. PubMed ID: 31016647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of gene expression profiles from cholestatic hepatotoxicants in vitro against human in vivo cholestasis.
    Van den Hof WFPM; Coonen MLJ; van Herwijnen M; Brauers K; Jennen D; Olde Damink SWM; Schaap FG; Kleinjans JCS
    Toxicol In Vitro; 2017 Oct; 44():322-329. PubMed ID: 28778767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.